Omron (OTCMKTS:OMRNY) Stock Price Up 5.9% – Still a Buy?

Omron Corp. (OTCMKTS:OMRNY) rose 5.9% on Friday . The stock traded as high as $33.11 and last traded at $33.06. Approximately 4,672 shares were traded during trading, a decline of 91% from the average daily volume of 49,645 shares. The stock had previously closed at $31.2150.

Analyst Ratings Changes

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Omron Stock Up 1.8%

The company has a debt-to-equity ratio of 0.13, a current ratio of 2.14 and a quick ratio of 1.40. The company has a 50-day simple moving average of $26.78 and a 200-day simple moving average of $26.77. The firm has a market cap of $6.88 billion, a PE ratio of 42.22, a price-to-earnings-growth ratio of 0.52 and a beta of 0.98.

Omron (OTCMKTS:OMRNY) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.19). The firm had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Analysts expect that Omron Corp. will post 0.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC lifted its stake in Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,129 shares of the company’s stock after buying an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is currently owned by institutional investors and hedge funds.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.